Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
82,30-11-2022,Amanfrom,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,30-11-2022,30-11-2022,,,10,OPD,
378,30-11-2022,mallam station,70 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> NEW,,No,Non-Insured,POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution | Daily |  For 7 Days  ],,,,30-11-2022,30-11-2022,,,50,OPD,
494,30-11-2022,NEW GBAWE ,87 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | BDS |  For 7 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ]",,,30-11-2022,30-11-2022,,,20,OPD,
650,29-11-2022,MALLAM ,46 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-11-2022,29-11-2022,,,10,OPD,
770,29-11-2022,SCC,37 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,Teacher,,29-11-2022,29-11-2022,,,0,OPD,
773,29-11-2022,gbawe-bulemi,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]",,,,29-11-2022,29-11-2022,,,10,OPD,
779,29-11-2022,tetegu,63 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-11-2022,29-11-2022,,,10,OPD,
804,29-11-2022,barrier old,65 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ],GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ],,,29-11-2022,29-11-2022,,,10,OPD,
828,29-11-2022,AWOSHIE,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,29-11-2022,29-11-2022,,,10,OPD,
909,29-11-2022,weija,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,29-11-2022,29-11-2022,,,10,OPD,
945,29-11-2022,"MATAHEKO
EMIT SCHOOL",44 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"G58.9 [Mononeuropathy, unspecified]  ==> NEW",No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,29-11-2022,29-11-2022,,,10,OPD,
1092,29-11-2022,DANSOMAN METHODIST,40 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-11-2022,29-11-2022,,,50,OPD,
1154,29-11-2022,ABLEKUMAH ODUMAN,64 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 2 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | q6h |  For 1 Days  ], ENOXAPARIN SODIUM (CLEXANE) INJECTION 40MG[ CLEXANE | 40MG/0.4ML | Injection | Daily |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Daily |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | q12h |  For 1 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 31 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], ENOXAPARIN SODIUM (CLEXANE) INJECTION 40MG[ CLEXANE | 40MG/0.4ML | Injection ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",Unemployed,,29-11-2022,29-11-2022,,,125,OPD,
1199,28-11-2022,awoshie ,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 30 Days  ]",,TRADER,,28-11-2022,28-11-2022,,,10,OPD,
1214,28-11-2022,GBAWE,76 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], DIAZEPAM INJECTION 10MG[ DIAZEPAM | 5MG/ML IN2ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], DIAZEPAM INJECTION 10MG[ DIAZEPAM | 5MG/ML IN2ML | Injection ]",Pensioner,,28-11-2022,28-11-2022,,,95,OPD,
1224,28-11-2022,"SCC
INSIDE",78 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,"MULTIVITAMIN SYRUP 125MG[ MULTIVITAMIN | 125ML | Syrup | BDS |  For 7 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | BDS |  For 30 Days  ]",,,,28-11-2022,28-11-2022,,,10,OPD,
1239,28-11-2022,WEIJA,56 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 10 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ]","IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",TRADER,,28-11-2022,28-11-2022,,,58,OPD,
1326,28-11-2022,amanseman,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E09.09 [Drug or chemical induced diabetes mellitus without complications]  ==> OLD,,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-11-2022,28-11-2022,,,10,OPD,
1328,28-11-2022,kasoa,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.649 [Type 2 diabetes mellitus with hypoglycemia without coma]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,28-11-2022,28-11-2022,,,10,OPD,
1353,28-11-2022,ODORKOR-BUSIA,60 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,28-11-2022,28-11-2022,,,10,OPD,159561
1355,28-11-2022,UPPER WEIJA,48 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | PRN |  For 1 Days  ]",,,,28-11-2022,28-11-2022,,,10,OPD,
1363,28-11-2022,"BORTIANOR
YAW NSIAH JNC",57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",TRADER,,28-11-2022,28-11-2022,,,10,OPD,
1415,28-11-2022,Weija ,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E09.09 [Drug or chemical induced diabetes mellitus without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,28-11-2022,28-11-2022,,,10,OPD,3226/17
1560,28-11-2022,KASOA AMERICAN TOWN ,47 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.42 [Other specified diabetes mellitus with diabetic polyneuropathy]  ==> NEW,,No,Insured,PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 14 Days  ],PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ],TRADER,,28-11-2022,28-11-2022,,,10,OPD,
1600,28-11-2022,kokorbitey,35 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",BUSINESS PERSON,,28-11-2022,28-11-2022,,,0,OPD,
2010,26-11-2022,KASOA,62 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,26-11-2022,26-11-2022,,,65,OPD,
2086,26-11-2022,ATICO,57 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.649 [Diabetes mellitus due to underlying condition with hypoglycemia without coma]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ]",Self Employed,,26-11-2022,26-11-2022,,,95,OPD,
2095,25-11-2022,ablekuman,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,"M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], IBUPROFEN TABLET 400MG[ IBUPROFEN | 400MG | Tablet | TID |  For 5 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BDS |  For 7 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 10 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], IBUPROFEN TABLET 400MG[ IBUPROFEN | 400MG | Tablet ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,25-11-2022,25-11-2022,,,10,OPD,
2135,25-11-2022,SCC,51 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I16.0 [Hypertensive urgency]  ==> NEW,No,Non-Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | QID |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]",,WELDER,,25-11-2022,25-11-2022,,,95,OPD,
2147,25-11-2022,WEIJA,59 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E11.620 [Type 2 diabetes mellitus with diabetic dermatitis]  ==> NEW,,No,Insured,DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 7 Days  ],DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ],,,25-11-2022,25-11-2022,,,20,OPD,14012165
2165,25-11-2022,ABLEKUMA ,71 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,I10. [Essential (primary) hypertension]  ==> RECURRING,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,25-11-2022,25-11-2022,,,10,OPD,
2166,25-11-2022,MCCHARTHY PRESBY CHURCH,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 30 Days  ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ]",,,,25-11-2022,25-11-2022,,,10,OPD,
2187,25-11-2022,AGAPE TOP,29 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,,Yes,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,25-11-2022,25-11-2022,,,60,OPD,
2409,25-11-2022,BULEMIN,76 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,I10. [Essential (primary) hypertension]  ==> RECURRING,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ]",,,,25-11-2022,25-11-2022,,,10,OPD,
2523,25-11-2022,ADASEMAN,69 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Non-Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,,,25-11-2022,25-11-2022,,,105,OPD,
2664,24-11-2022,mccarthy Assembles of God Church,56 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution | Stat |  For 1 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]","POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,24-11-2022,24-11-2022,,,50,OPD,
2667,24-11-2022,kasoa american junction,23 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 7 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,24-11-2022,24-11-2022,,,10,OPD,
2671,24-11-2022,kasoa galeliya,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]",,,,24-11-2022,24-11-2022,,,20,OPD,
2684,24-11-2022,KASOA,38 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,,Yes,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,24-11-2022,24-11-2022,,,15,OPD,
2686,24-11-2022,MCCARTHY TOP,37 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,I10. [Essential (primary) hypertension]  ==> RECURRING,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",,,24-11-2022,24-11-2022,,,15,OPD,
2699,24-11-2022,MALLAM,48 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ]",,bussiness,,24-11-2022,24-11-2022,,,85,OPD,
2922,24-11-2022,ablekuman,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,I10. [Essential (primary) hypertension]  ==> RECURRING,No,Non-Insured,"ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BDS |  For 7 Days  ], AZITHROMYCIN CAPSULE 250MG[ AZITHROMYCIN | 250MG | Tablet | Daily |  For 7 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], AZITHROMYCIN CAPSULE 250MG[ AZITHROMYCIN | 250MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,24-11-2022,24-11-2022,,,10,OPD,
3138,24-11-2022,scc,43 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,I10. [Essential (primary) hypertension]  ==> RECURRING,No,Insured,"BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]","BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,24-11-2022,24-11-2022,,,0,OPD,
3180,24-11-2022,kasoa,47 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,24-11-2022,24-11-2022,,,10,OPD,
3298,23-11-2022,weija ,44 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,23-11-2022,23-11-2022,,,20,OPD,
3339,23-11-2022,ABLEKUMAH-AGAPE,49 Year(s),Male,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E08.3213 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral]  ==> NEW","H25.42 [Posterior subcapsular polar age-related cataract, left eye]  ==> NEW",No,Insured,IOP[ IOP |  | Drops | Stat |  For 1 Days  ],IOP[ IOP |  | Drops ],,,23-11-2022,23-11-2022,,,100,OPD,27389/13  MR-1B-E6-11
3343,23-11-2022,ABLEKUMA-AGAPE,57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,,,,,23-11-2022,23-11-2022,,,10,OPD,
3395,23-11-2022,SCC,37 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> NEW",,No,Insured,,,Teacher,,23-11-2022,23-11-2022,,,0,OPD,
3401,23-11-2022,KASOA ,58 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"G44.99 [Other trigeminal autonomic cephalgias (TAC), not intractable]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 1 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | PRN |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,23-11-2022,23-11-2022,,,20,OPD,
3465,23-11-2022,awoshie,54 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,,,23-11-2022,23-11-2022,,,0,OPD,
3602,23-11-2022,OLD BARRIER ,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> RECURRING,I10. [Essential (primary) hypertension]  ==> RECURRING,No,Non-Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ]",,,,23-11-2022,23-11-2022,,,25,OPD,
3623,23-11-2022,Ablekuma agape,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,"E78.5 [Hyperlipidaemia, unspecified]  ==> RECURRING",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ]",,bussiness,,23-11-2022,23-11-2022,,,70,OPD,
3737,23-11-2022,"GBAWE
BULEMIN",48 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E08.3211 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye]  ==> NEW",,No,Insured,"II CARE CAPSULES[ II CARE |  | Capsule | Nocte |  For 30 Days  ], NORMO TEARS EYE DROP[ HYDROMELLOSE | 10ML | Drops | QID |  For 30 Days  ]","II CARE CAPSULES[ II CARE |  | Capsule ], NORMO TEARS EYE DROP[ HYDROMELLOSE | 10ML | Drops ]",,,23-11-2022,23-11-2022,,,80,OPD,
3749,23-11-2022,MALLAM,36 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,Yes,Insured,,,,,23-11-2022,23-11-2022,,,0,OPD,
3750,23-11-2022,WEIJA,46 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> RECURRING,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,23-11-2022,23-11-2022,,,10,OPD,
3868,23-11-2022,"GBAWE
CP",50 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Non-Insured,,,MECHANICAL ENGINEER,,23-11-2022,23-11-2022,,,50,OPD,
3871,23-11-2022,WEIJA,49 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,"A41.9 [Sepsis, unspecified]  ==> NEW",No,Non-Insured,"DIAZEPAM INJECTION 10MG[ DIAZEPAM | 5MG/ML IN2ML | Injection | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | BDS |  For 2 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","DIAZEPAM INJECTION 10MG[ DIAZEPAM | 5MG/ML IN2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",business man,,23-11-2022,23-11-2022,,,105,OPD,
4067,22-11-2022,"NEW BORTIANOR , KASSAPA ",52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]",,TRADER,,22-11-2022,22-11-2022,,,20,OPD,
4074,22-11-2022,MCCARTHY HILL,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,22-11-2022,22-11-2022,,,20,OPD,
4464,22-11-2022,NEW GBAWE ,87 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,N34.1 [Nonspecific urethritis]  ==> NEW,No,Insured,"CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | Stat |  For 1 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,22-11-2022,22-11-2022,,,137,OPD,
4558,21-11-2022,WEIJA- CHOICE,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,21-11-2022,21-11-2022,,,70,OPD,
4559,21-11-2022,mallam,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,21-11-2022,21-11-2022,,,20,OPD,
4568,21-11-2022,"KASOA, OFAAKOR",69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 14 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",,,21-11-2022,21-11-2022,,,20,OPD,
4572,21-11-2022,OBOLOGO,44 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,21-11-2022,21-11-2022,,,20,OPD,
4573,21-11-2022,gbawe top base,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-11-2022,21-11-2022,,,20,OPD,
4574,21-11-2022,OLEBU  ABLEKUMA,61 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",LOTTO RECEIVER,,21-11-2022,21-11-2022,,,20,OPD,
4576,21-11-2022,MALLAM ABASE,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 14 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,21-11-2022,21-11-2022,,,10,OPD,
4597,21-11-2022,"NEW BORTIANOR , KASSAPA ",52 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E13.36 [Other specified diabetes mellitus with diabetic cataract]  ==> NEW,H11.02 [Unspecified pterygium of left eye]  ==> NEW,No,Insured,NORMO TEARS EYE DROP[ HYDROMELLOSE | 10ML | Drops | TID |  For 14 Days  ],,TRADER,,21-11-2022,21-11-2022,,,20,OPD,
4651,21-11-2022,weija,71 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 0 Days  ]","ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,21-11-2022,21-11-2022,,,10,OPD,
4967,21-11-2022,MANHEAN,66 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,21-11-2022,21-11-2022,,,60,OPD,
5055,21-11-2022,barrier old,65 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,21-11-2022,21-11-2022,,,0,OPD,
5108,21-11-2022,kasoa,58 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,21-11-2022,21-11-2022,,,0,OPD,
5201,21-11-2022,"GBAWE
BULEMIN",48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,21-11-2022,21-11-2022,,,60,OPD,
5212,21-11-2022,"new bortianor, las vegas",60 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 5 Days  ],,Unemployed,,21-11-2022,21-11-2022,,,155,OPD,
5357,20-11-2022,MACCARTHY HILL,65 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Non-Insured,METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | Stat |  For 1 Days  ],,,,20-11-2022,20-11-2022,,,30,OPD,
5377,20-11-2022,McCarthy,80 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","N77.01 [Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere]  ==> NEW, K59.09 [Other constipation]  ==> RECURRING",No,Insured,"CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream | BDS |  For 5 Days  ], CLOTRIMAZOLE PESSARY 100MG[ CLOTRIMAZOLE PESSARY | 100MG | Tablet | OD |  For 5 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 5 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 5 Days  ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup | BDS |  For 5 Days  ]","CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream ], CLOTRIMAZOLE PESSARY 100MG[ CLOTRIMAZOLE PESSARY | 100MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup ]",,,20-11-2022,20-11-2022,,,10,OPD,
5381,20-11-2022,MCCARTHY HILL,60 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,Pensioner,,20-11-2022,20-11-2022,,,95,OPD,
5429,20-11-2022,"KASOA, KALABULE",49 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> RECURRING,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,SPRAYER,,20-11-2022,20-11-2022,,,80,OPD,
5435,20-11-2022,SOWOTOUM MARKET,48 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,"A01.4 [Paratyphoid fever, unspecified]  ==> NEW",No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BID |  For 1 Days  ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | TID |  For 1 Days  ]",,PAINTER,,20-11-2022,20-11-2022,,,370,OPD,
5607,19-11-2022,sowutuom,52 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW",No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | OD |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",TRADER,,19-11-2022,19-11-2022,,,65,OPD,
5715,18-11-2022,TETEGU,64 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E08.3213 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral]  ==> NEW",H52.6 [Other disorders of refraction]  ==> NEW,No,Insured,NORMO TEARS EYE DROP[ HYDROMELLOSE | 10ML | Drops | QID |  For 1 Days  ],,,,18-11-2022,18-11-2022,,,80,OPD,
5786,18-11-2022,"LAPAZ
NII BOI TOWN",46 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","M10.09 [Idiopathic gout, multiple sites]  ==> NEW, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW, A01.4 [Paratyphoid fever, unspecified]  ==> NEW",No,Non-Insured,,,TRADER,,18-11-2022,18-11-2022,,,50,OPD,8B-C3-124
5895,18-11-2022,BORTIANOR,85 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,Retired,,18-11-2022,18-11-2022,,,10,OPD,
6104,17-11-2022,malla,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-11-2022,17-11-2022,,,10,OPD,
6115,17-11-2022,MALLAM,35 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]",,,,17-11-2022,17-11-2022,,,10,OPD,
6118,17-11-2022,KWASHIMAN,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,B37.3 [Candidiasis of vulva and vagina]  ==> NEW,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], Polygynax (pessaries)[  |  | Pessary | Nocte |  For 12 Days  ]",,,,17-11-2022,17-11-2022,,,10,OPD,
6123,17-11-2022,AYIGBE TOWN,35 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,17-11-2022,17-11-2022,,,10,OPD,
6128,17-11-2022,"GBAWE , TOP BASE",46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,CLEGY,,17-11-2022,17-11-2022,,,65,OPD,
6150,17-11-2022,KASOA TUBA,55 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,"J18.0 [Bronchopneumonia, unspecified]  ==> NEW, I26.90 [Septic pulmonary embolism without acute cor pulmonale]  ==> NEW",No,Non-Insured,"RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | q12h |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | q8h |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-11-2022,17-11-2022,,,200,OPD,
6322,17-11-2022,ANYAA NIC,58 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,,,17-11-2022,17-11-2022,,,40,OPD,
6332,17-11-2022,KASOA ,72 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,Z86.31 [Personal history of diabetic foot ulcer]  ==> NEW,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BDS |  For 1 Days  ]",,,,17-11-2022,17-11-2022,,,10,OPD,
6337,17-11-2022,"NIC
",41 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,Fashion Designer,,17-11-2022,17-11-2022,,,0,OPD,
6369,17-11-2022,Amasaman,65 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",M79.7 [Fibromyalgia]  ==> NEW,No,Insured,VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ],,,,17-11-2022,17-11-2022,,,10,OPD,
6373,17-11-2022,"WEIJA ,OLD BARRIER",35 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Stat |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-11-2022,17-11-2022,,,0,OPD,
6724,16-11-2022,new weija azumah,65 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,16-11-2022,16-11-2022,,,10,OPD,
6733,16-11-2022,Ablekuma agape,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,bussiness,,16-11-2022,16-11-2022,,,65,OPD,
6765,16-11-2022,AGAPE TOP,29 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,"J18.0 [Bronchopneumonia, unspecified]  ==> NEW, B37.3 [Candidiasis of vulva and vagina]  ==> NEW",Yes,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,16-11-2022,16-11-2022,,,95,OPD,
6786,16-11-2022,"WEIJA
STATION",52 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 5 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,16-11-2022,16-11-2022,,,10,OPD,
7196,16-11-2022,KWASHIMAN GAG SCHOOL,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,16-11-2022,16-11-2022,,,10,OPD,
7394,15-11-2022,KASOA,57 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.42 [Type 2 diabetes mellitus with diabetic polyneuropathy]  ==> NEW,,No,Insured,,,,,15-11-2022,15-11-2022,,,10,OPD,
7407,15-11-2022,"NYAMESTE 
LAPAZ",33 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,15-11-2022,15-11-2022,,,10,OPD,
7416,15-11-2022,KASOA,57 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BDS |  For 14 Days  ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule | BDS |  For 14 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | BDS |  For 7 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ]",,,15-11-2022,15-11-2022,,,10,OPD,
7418,15-11-2022,GBAWE BLUE CROSS,72 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,15-11-2022,15-11-2022,,,60,OPD,
7419,15-11-2022,ANYAA,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,15-11-2022,15-11-2022,,,15,OPD,
7442,15-11-2022,AMANFROM-GALILEA,57 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",M79.7 [Fibromyalgia]  ==> OLD,No,Non-Insured,"DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | BDS |  For 5 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ]","DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,15-11-2022,15-11-2022,,,60,OPD,
7553,15-11-2022,"ODOKOR MAKRT
",34 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> OLD",,No,Insured,,,,,15-11-2022,15-11-2022,,,0,OPD,
7713,15-11-2022,GBAWE,73 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Non-Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | PRN |  For 5 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | TDS |  For 1 Days  ]",,,,15-11-2022,15-11-2022,,,10,OPD,
7843,15-11-2022,"AWOSHIE 
STATION",74 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 30 Days  ]","LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ]",,,15-11-2022,15-11-2022,,,20,OPD,
8026,14-11-2022,"KASOAL, TIPPER JUCTION ",57 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]",,,,14-11-2022,14-11-2022,,,10,OPD,
8040,14-11-2022,tetegu,45 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,14-11-2022,14-11-2022,,,10,OPD,
8043,14-11-2022,AWOSHIE,44 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,14-11-2022,14-11-2022,,,10,OPD,
8046,14-11-2022,AMERICAN TOWN KASOA,55 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,14-11-2022,14-11-2022,,,15,OPD,
8055,14-11-2022,"GBAWE
BULEMIN",29 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,14-11-2022,14-11-2022,,,10,OPD,
8139,14-11-2022,KASOA,63 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"G58.9 [Mononeuropathy, unspecified]  ==> NEW",No,Non-Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,,,14-11-2022,14-11-2022,,,10,OPD,6082/19
8208,14-11-2022,"ANYAA
NIC",29 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,14-11-2022,14-11-2022,,,10,OPD,
8429,14-11-2022,ODORKOR 4 AND 5,49 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.628 [Type 2 diabetes mellitus with other skin complications]  ==> NEW,,No,Non-Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BDS |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BDS |  For 10 Days  ]",,TRADER,,14-11-2022,14-11-2022,,,90,OPD,
8460,14-11-2022,KWASHIEMAN,57 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,14-11-2022,14-11-2022,,,10,OPD,
8616,14-11-2022,ANYAA NIC,58 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], DICLOFENAC TABLET 100MG[ LOFNAC | 100MG | Tablet | BDS |  For 5 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], DICLOFENAC TABLET 100MG[ LOFNAC | 100MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,14-11-2022,14-11-2022,,,70,OPD,
8775,14-11-2022,OLD BORTIANOR,50 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,K29.1 [Other acute gastritis]  ==> NEW,No,Insured,"OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 14 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | TDS |  For 5 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], ANTACID SUSPENSION 200MLS[ ANTACID  | 200ML | Suspension | TDS |  For 14 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BDS |  For 14 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ANTACID SUSPENSION 200MLS[ ANTACID  | 200ML | Suspension ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,14-11-2022,14-11-2022,,,65,OPD,
8792,14-11-2022,"MCCARTHY HILL , ",71 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,14-11-2022,14-11-2022,,,95,OPD,
8855,13-11-2022,ODORKOR,43 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Daily |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Daily |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | Stat |  For 1 Days  ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,13-11-2022,13-11-2022,,,20,OPD,
8918,13-11-2022,BORTIANOR-APLAKU,49 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,"K29.1 [Other acute gastritis]  ==> NEW, D64.89 [Other specified anemias]  ==> NEW, I10. [Essential (primary) hypertension]  ==> OLD",No,Insured,"METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | q8h |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | OD |  For 15 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BDS |  For 30 Days  ], FOLIC ACID TABLET 5MG[ FOLIC ACID | 5MG | Tablet | OD |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], DEXTROSE IN SODIUM CHLORIDE INF","METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], FOLIC ACID TABLET 5MG[ FOLIC ACID | 5MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ]",TRADER,,13-11-2022,13-11-2022,,,165,OPD,
9032,12-11-2022,NEW WEIJA,65 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,"FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection | BDS |  For 2 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,12-11-2022,12-11-2022,,,95,OPD,1B-A4-91
9071,11-11-2022,"AWOSHIE, A-LANG",57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,11-11-2022,11-11-2022,,,20,OPD,
9104,11-11-2022,WHITE CROSS,53 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,"A09.9 [Gastroenteritis and colitis of unspecified origin]  ==> NEW, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Non-Insured,"METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | TID |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | BID |  For 1 Days  ], CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet | BID |  For 7 Days  ]","METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet ]",TRADER,,11-11-2022,11-11-2022,,,185,OPD,
9533,11-11-2022,KASOA-AKWELEY,65 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]",,Pensioner,,11-11-2022,11-11-2022,,,65,OPD,
9569,10-11-2022,dansoman,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], ACECLOFENAC TABLET 100MG[ ZULU | 100MG | Tablet | BDS |  For 5 Days  ]",,,,10-11-2022,10-11-2022,,,10,OPD,
9584,10-11-2022,NEW BORTIANOR-AYIGBE TOWN,67 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",TRADER,,10-11-2022,10-11-2022,,,50,OPD,46138/18 MR-1B-D2-3
9608,10-11-2022,KASOA FANKOR,41 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD",N34.2 [Other urethritis]  ==> NEW,No,Non-Insured,"CEFIXIME TABLET 200MG[ CEFIXIME | 200MG | Tablet | BID |  For 7 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","CEFIXIME TABLET 200MG[ CEFIXIME | 200MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,10-11-2022,10-11-2022,,,50,OPD,
9658,10-11-2022,south mc carthy,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]",,,,10-11-2022,10-11-2022,,,20,OPD,
9689,10-11-2022,"GBAWE 
ZERO TROTRO STATION ",50 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 7 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,10-11-2022,10-11-2022,,,25,OPD,
9738,10-11-2022,"SOWUTUOM 
CHOP BAR",73 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 0 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 0 Days  ]",,,,10-11-2022,10-11-2022,,,20,OPD,
9774,10-11-2022,"GBAWE , CP",76 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,10-11-2022,10-11-2022,,,50,OPD,
9832,10-11-2022,gbawe,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,10-11-2022,10-11-2022,,,10,OPD,
10004,10-11-2022,WEIJA NEW TOWN,61 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> OLD, D64.89 [Other specified anemias]  ==> NEW",No,Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | TID |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TID |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 2 Days  ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ]","CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ]",TRADER,,10-11-2022,10-11-2022,,,185,OPD,
10322,09-11-2022,MANHEAN,66 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TDS |  For 5 Days  ]",,,,09-11-2022,09-11-2022,,,275,OPD,
10619,09-11-2022,MALLAM MASLACHI,34 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> OLD",,Yes,Insured,,,none,,09-11-2022,09-11-2022,,,0,OPD,
10801,09-11-2022,KWASHIMAN GAG SCHOOL,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> OLD,,No,Insured,,,,,09-11-2022,09-11-2022,,,10,OPD,
10951,08-11-2022,ODORKOR,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> RECURRING,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Daily |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Daily |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",,,08-11-2022,08-11-2022,,,20,OPD,
10953,08-11-2022,,20 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,B37.3 [Candidiasis of vulva and vagina]  ==> NEW,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], Polygynax (pessaries)[  |  | Pessary | Nocte |  For 12 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], Polygynax (pessaries)[  |  | Pessary ]",,,08-11-2022,08-11-2022,,,20,OPD,
10958,08-11-2022,ODORKOR. GLORYLAND,51 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,08-11-2022,08-11-2022,,,20,OPD,
10970,08-11-2022,gbawe,64 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,08-11-2022,08-11-2022,,,30,OPD,
10971,08-11-2022,santa maria-drug store,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,,,08-11-2022,08-11-2022,,,20,OPD,
10981,08-11-2022,ABLEKUIMA ,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 0 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,08-11-2022,08-11-2022,,,20,OPD,
11053,08-11-2022,BORTIANOR POLLY TANK,40 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,Yes,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet | BDS |  For 7 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ]",Unemployed,,08-11-2022,08-11-2022,,,200,OPD,
11236,08-11-2022,MENDSKROM,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Non-Insured,RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | OD |  For 30 Days  ],,TRADER,,08-11-2022,08-11-2022,,,25,OPD,
11250,08-11-2022,AMERICAN TOWN KASOA,55 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,08-11-2022,08-11-2022,,,10,OPD,
11266,08-11-2022,MANHEAN,66 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]",,,,08-11-2022,08-11-2022,,,60,OPD,
11326,08-11-2022,McCarthy,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ]","BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,08-11-2022,08-11-2022,,,10,OPD,
11340,08-11-2022,AWOSHIE,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,08-11-2022,08-11-2022,,,20,OPD,
11563,08-11-2022,MALLAM,48 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,M32.19 [Other organ or system involvement in systemic lupus erythematosus]  ==> OLD,No,Insured,,,,,08-11-2022,08-11-2022,,,65,OPD,
11613,08-11-2022,"GBAWE
CLOSE TO THE CEMENTRY",60 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.622 [Diabetes mellitus due to underlying condition with other skin ulcer]  ==> NEW,,No,Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BDS |  For 7 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | OD |  For 30 Days  ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 30ML[ DREZ  | 30ML | Solution | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,,,08-11-2022,08-11-2022,,,65,OPD,
11629,08-11-2022,ABLEKUMAH-MAAME KRAN,47 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,M79.7 [Fibromyalgia]  ==> NEW,No,Insured,"PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | BDS |  For 1 Days  ]","PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ]",,,08-11-2022,08-11-2022,,,115,OPD,
11641,07-11-2022,kasoa operkuman,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,07-11-2022,07-11-2022,,,10,OPD,
11645,07-11-2022,gbawe cp,65 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,07-11-2022,07-11-2022,,,20,OPD,
11647,07-11-2022,KASOA-BODWEASE RD,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,07-11-2022,07-11-2022,,,10,OPD,13895/17 MR9A-A3-113
11650,07-11-2022,Gbawe,79 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,07-11-2022,07-11-2022,,,20,OPD,
11652,07-11-2022,kasoa,32 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,07-11-2022,07-11-2022,,,20,OPD,
11654,07-11-2022,dansoman,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,07-11-2022,07-11-2022,,,10,OPD,
11656,07-11-2022,"GBAWE , TELECOM",70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,07-11-2022,07-11-2022,,,20,OPD,
11680,07-11-2022,AKWELEY NEW TOWN,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,07-11-2022,07-11-2022,,,50,OPD,
11764,07-11-2022,"WEIJA
WHITECROSS",40 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]",,,,07-11-2022,07-11-2022,,,20,OPD,
11808,07-11-2022,scc,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 0 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,07-11-2022,07-11-2022,,,10,OPD,
11832,07-11-2022,"AGAPE
GONSE",49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], IRON(III)POLYMALTOSE COMPLEX SUSPENSION[ IRON (111)POLYMALTOSE COMPLEX  | 200ML | Syrup | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,TRADER,,07-11-2022,07-11-2022,,,20,OPD,
11868,07-11-2022,weija,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,07-11-2022,07-11-2022,,,60,OPD,
11969,07-11-2022,LOIS PLAZA,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,,,,,07-11-2022,07-11-2022,,,25,OPD,
11988,07-11-2022,TUBA-TOLL BOTH,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.42 [Other specified diabetes mellitus with diabetic polyneuropathy]  ==> NEW,,No,Insured,VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ],VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ],,,07-11-2022,07-11-2022,,,60,OPD,
12061,07-11-2022,HONGONG KWASHIEMAN,93 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], CINNARIZINE (STUGERON) 25MG[ STUGERON | 25MG | Tablet | BDS |  For 5 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CINNARIZINE (STUGERON) 25MG[ STUGERON | 25MG | Tablet ]",,,07-11-2022,07-11-2022,,,10,OPD,
12076,07-11-2022,Ablekuma agape,58 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,B54. [Unspecified malaria]  ==> NEW,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Daily |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Daily |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",bussiness,,07-11-2022,07-11-2022,,,90,OPD,
12445,07-11-2022,"SAMPA VALLEY , WEIJA ",62 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Unemployed,,07-11-2022,07-11-2022,,,10,OPD,
12529,06-11-2022,GBAWE ZERO,77 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.649 [Type 2 diabetes mellitus with hypoglycemia without coma]  ==> NEW,,No,Insured,"DEXTROSE INFUSION 5% 500ML[ DEXTROSE | 5% 500ML | Infusion | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 2 Days  ]","DEXTROSE INFUSION 5% 500ML[ DEXTROSE | 5% 500ML | Infusion ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ]",Unemployed,,06-11-2022,06-11-2022,,,65,OPD,
12564,06-11-2022,NEW GBAWE ,87 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,G46.03 [Brain stem stroke syndrome]  ==> NEW,No,Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ]",,,,06-11-2022,06-11-2022,,,105,OPD,
12594,05-11-2022,LOIS PLAZA,67 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"I16.0 [Hypertensive urgency]  ==> NEW, N34.2 [Other urethritis]  ==> NEW",No,Insured,"CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet | BID |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 30 Days  ]","CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,05-11-2022,05-11-2022,,,260,OPD,
12684,05-11-2022,NYANYANO,68 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 14 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,05-11-2022,05-11-2022,,,30,OPD,
12706,05-11-2022,WEIJA,62 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Child,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",Unemployed,,05-11-2022,05-11-2022,,,95,OPD,
12760,04-11-2022,zogon junction,74 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,04-11-2022,04-11-2022,,,20,OPD,
12767,04-11-2022,weija ,67 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,04-11-2022,04-11-2022,,,10,OPD,
12858,04-11-2022,SUHUM,64 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,04-11-2022,04-11-2022,,,10,OPD,
12887,04-11-2022,anyaa,81 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,"M43.06 [Spondylolysis, lumbar region]  ==> OLD",No,Insured,"OSTEOCARE TABLET[ OSTEOCARE |  | Tablet | OD |  For 30 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]",,,,04-11-2022,04-11-2022,,,20,OPD,
12944,04-11-2022,NSAWAM,67 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.649 [Diabetes mellitus due to underlying condition with hypoglycemia without coma]  ==> OLD,,No,Non-Insured,,,TRADER,,04-11-2022,04-11-2022,,,95,OPD,
12948,04-11-2022,ANYAA,56 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,04-11-2022,04-11-2022,,,10,OPD,
13240,04-11-2022,TESHIE,67 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,L03.116 [Cellulitis of left lower limb]  ==> NEW,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Daily |  For 2 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TID |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ]",,,04-11-2022,04-11-2022,,,50,OPD,
13300,03-11-2022,ayawaso,75 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,03-11-2022,03-11-2022,,,20,OPD,
13311,03-11-2022,anyaa market,87 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,Unemployed,,03-11-2022,03-11-2022,,,20,OPD,
13312,03-11-2022,kwashieman,53 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,03-11-2022,03-11-2022,,,70,OPD,
13313,03-11-2022,bubiashie,57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,03-11-2022,03-11-2022,,,10,OPD,
13315,03-11-2022,kasoa,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,03-11-2022,03-11-2022,,,10,OPD,
13331,03-11-2022,"GBAWE
 PALACE",51 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,03-11-2022,03-11-2022,,,20,OPD,
13525,03-11-2022,BULEMIN,76 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,03-11-2022,03-11-2022,,,20,OPD,
13560,03-11-2022,GBAWE,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,03-11-2022,03-11-2022,,,10,OPD,
13667,03-11-2022,DANKUMAN,79 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection | Daily |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection ]",,,03-11-2022,03-11-2022,,,10,OPD,
13688,03-11-2022,kasoa,66 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,03-11-2022,03-11-2022,,,0,OPD,
13925,02-11-2022,dansomn,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",Para Professional,,02-11-2022,02-11-2022,,,10,OPD,
13943,02-11-2022,mallam abase,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | TDS |  For 15 Days  ], FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection | Daily |  For 20 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection ]",,,02-11-2022,02-11-2022,,,20,OPD,
13978,02-11-2022,MALLAM-MASALACHI,75 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,,,,,02-11-2022,02-11-2022,,,20,OPD,
14044,02-11-2022,Dansoman,57 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,02-11-2022,02-11-2022,,,0,OPD,
14149,02-11-2022,"NORTH KANESHIE
DEMOND",53 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",Self Employed,,02-11-2022,02-11-2022,,,70,OPD,
14270,02-11-2022,"KASOA, NEW MARKET 
OPPSITE OPPORTUNITY",57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,02-11-2022,02-11-2022,,,50,OPD,
14423,02-11-2022,WEIJA ,57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | TID |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | q6h |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,ADMINISTRATOR,,02-11-2022,02-11-2022,,,10,OPD,
14554,02-11-2022,WEIJA ,57 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,ADMINISTRATOR,,02-11-2022,02-11-2022,,,95,OPD,
14597,02-11-2022,AGEGE,51 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 5 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]",,,,02-11-2022,02-11-2022,,,20,OPD,
14636,01-11-2022,upper weija,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,01-11-2022,01-11-2022,,,10,OPD,
14643,01-11-2022,Weija water works ,59 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,01-11-2022,01-11-2022,,,20,OPD,
14644,01-11-2022,mallam ,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,01-11-2022,01-11-2022,,,20,OPD,
14645,01-11-2022,KASOA TUBA,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ]","CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ]",,,01-11-2022,01-11-2022,,,10,OPD,
14646,01-11-2022,ablekuma abease,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | TDS |  For 15 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",professional,,01-11-2022,01-11-2022,,,20,OPD,
14647,01-11-2022,odorkor,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 1 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 1 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 1 Days  ], TAB RENEURON  20MG[ RENEURON | 20MG | Tablet | Daily |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], TAB RENEURON  20MG[ RENEURON | 20MG | Tablet ]",,,01-11-2022,01-11-2022,,,10,OPD,
14652,01-11-2022,SCC OPP MALL,60 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,01-11-2022,01-11-2022,,,25,OPD,
14653,01-11-2022,"TUBA , IIRGATION FARMS",54 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,01-11-2022,01-11-2022,,,20,OPD,
14662,01-11-2022,AMANFRO-RIVER SIDE,67 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,01-11-2022,01-11-2022,,,0,OPD,
14740,01-11-2022,SCC,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,01-11-2022,01-11-2022,,,10,OPD,
14803,01-11-2022,kwashieman,47 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,01-11-2022,01-11-2022,,,0,OPD,
14822,01-11-2022,apleku,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,01-11-2022,01-11-2022,,,20,OPD,
14891,01-11-2022,upper weija,52 Year(s),Female,,,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | PRN |  For 15 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TID |  For 10 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,,,01-11-2022,01-11-2022,,,0,OPD,
14908,01-11-2022,"WEIJA 
PRESBY PRIMARY",57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 30 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ]",,,01-11-2022,01-11-2022,,,20,OPD,
14924,01-11-2022,KWASHIEBU,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ],,FOOD SELLER,,01-11-2022,01-11-2022,,,25,OPD,
15005,01-11-2022,KASOA AKWELEY,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 0 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",TRADER,,01-11-2022,01-11-2022,,,20,OPD,
